Koyfin Home > Directory > Health Care > Aeglea Biothera > Cash and Short-Term Investments

Aeglea Biothera Cash and Short-Term Investments Chart (AGLE)

Aeglea Biothera annual/quarterly Cash and Short-Term Investments from 2014 to 2020.
  • Aeglea Biothera Cash and Short-Term Investments for the quarter ending June 06, 2020 was $158m a 43.76% increase of 69m year over year
  • Aeglea Biothera Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $158m a 43.76% increase of 69m year over year
  • Aeglea Biothera Annual Cash and Short-Term Investments for 2019 was $72m a -3.56% decrease of -3m from 2018
  • Aeglea Biothera Annual Cash and Short-Term Investments for 2018 was $75m a 32.50% increase of 24m from 2017
  • Aeglea Biothera Annual Cash and Short-Term Investments for 2017 was $50m a -26.25% decrease of -13m from 2016
Other Balance Sheet Metrics:
  • Aeglea Biothera Total Assets for the quarter ending September 09, 2018 was $71m a 21.33% increase of 15m year over year
  • Aeglea Biothera Other Liabilities for the quarter ending December 12, 2018 was $0m a -40.28% decrease of 0m year over year
  • Aeglea Biothera Total Equity for the quarter ending September 09, 2018 was $64m a 20.95% increase of 13m year over year
View Chart On Koyfin

Quarterly AGLE Cash and Short-Term Investments Data

06/2020$158m
03/2020$49m
12/2019$72m
09/2019$89m
06/2019$106m
03/2019$124m
12/2018$75m
09/2018$65m
06/2018$72m
03/2018$43m

Annual AGLE Cash and Short-Term Investments Data

2019$72m
2018$75m
2017$50m
2016$64m
2015$33m
2014$3m
2013$5m